Sanofi India Plans to Sell Pharmaceutical Manufacturing Site in India to Zentiva
September 11 2019 - 02:46AM
Dow Jones News
By P.R.Venkat
Sanofi India Ltd. (500674.BY) said it is planning to sell a
pharmaceutical manufacturing facility in the western Indian state
of Gujarat to Zentiva.
Sanofi India, a unit of France-based Sanofi S.A. (SAN.FR), is
selling the Ankleshwar site for 2.62 billion Indian rupees ($36.4
million), the company said in a statement on Wednesday.
The Ankleshwar site has a chemistry and biotechnology
development centre, and manufactures both intermediates and
pharmaceutical formulations. Sanofi's Ankleshwar site manufactures
more than six billion tablets annually that include painkiller
brands like Combiflam.
Write to venkat.pr@wsj.com
(END) Dow Jones Newswires
September 11, 2019 02:31 ET (06:31 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Feb 2024 to Mar 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2023 to Mar 2024